2015
DOI: 10.1016/j.yexmp.2015.03.003
|View full text |Cite
|
Sign up to set email alerts
|

Complexes between insulin-like growth factor binding proteins and alpha-2-macroglobulin in patients with tumor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 23 publications
0
6
0
Order By: Relevance
“…The levels of IGFBP-1 may vary depending on the type of tumours. 29 Unfortunately, there was no such information available in this study as only overall cancer has been analysed. Although the mechanisms behind an increased risk of cancer are not known, one may speculate in the regulating role of IGFBP-1 on the growth hormone (GH) axis and cell growth.…”
Section: Discussionmentioning
confidence: 99%
“…The levels of IGFBP-1 may vary depending on the type of tumours. 29 Unfortunately, there was no such information available in this study as only overall cancer has been analysed. Although the mechanisms behind an increased risk of cancer are not known, one may speculate in the regulating role of IGFBP-1 on the growth hormone (GH) axis and cell growth.…”
Section: Discussionmentioning
confidence: 99%
“…IGF-1 plasma or serum levels have been reported to be increased in patients with a variety of cancers, including colorectal adenoma, malignant melanoma, breast cancer, non-small cell lung cancer [ 4 6 ]. However, conflicting results have been observed in studies conducted in prostate cancer, epithelial ovarian cancer, breast cancer, and oral cancer [ 7 10 ]. In addition, serum levels of IGFBP-1 have been reported to be increased in metastatic prostate and oral cancers, but not in pancreatic, non-metastatic colorectal or endometrial cancers [ 11 13 ].…”
Section: Introductionmentioning
confidence: 99%
“…The best known function of α 2 M is its ability to trap covalently a broad spectrum of proteases and facilitate their clearance via interaction with the low-density lipoprotein receptor-related protein (LRP) [ 1 – 3 ]. α 2 M has also been shown to facilitate the clearance of a diverse range of non-covalently bound ligands including the Alzheimer’s disease-associated amyloid β-peptide (Aβ) [ 4 , 5 ] and many cytokines and growth factors [ 6 10 ]. The binding of α 2 M to heat-denatured and amyloidogenic peptides and proteins inhibits their aggregation and α 2 M is found co-localized with misfolded proteins in disease states [ 11 17 ].…”
Section: Introductionmentioning
confidence: 99%